Liver Cancer Trial, Recruiting NCT05314400 Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT05314400
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, of any gender
  • People who have been diagnosed with colorectal cancer, confirmed by a tissue biopsy
  • People whose previous scans showed spots on the liver that may be cancer that has spread there
  • People who are willing and able to follow the study procedures for the full duration of the trial
  • People who are able to sign and date a consent form agreeing to take part
  • People who are physically able to undergo MRI scans as required by the study

Who may not be able to join:

  • People who have an implanted medical device or metal object in their body that is not safe to use near an MRI machine
  • People whose kidneys are not working well enough, based on a specific blood test result (confirm with trial site)
  • People who experience severe claustrophobia (fear of enclosed spaces) that cannot be managed with oral medication
  • People who have had a documented serious allergic reaction to the dye used in MRI scans (called gadolinium-based contrast agent)
  • People whose body weight exceeds the safe limit for the MRI table used in the study
  • People who are pregnant
  • People whose liver cancer spread is so extensive that surgery to remove it would not be possible
  • People with severely reduced liver function, based on a specific medical grading scale (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 519-685-8500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
1 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Diagnostic accuracy of abbreviated versus full MRI protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov